Nicotine Immunization
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Dr. Larry Kaskel is joined by Dr. Frank Vocci, Director of the Division of Pharmacotherapies and Medical Consequences of Drug Abuse at the National Institute on Drug Abuse at the NIH. He will discuss NicVAX, an anti-smoking vaccine that keeps nicotine molecules from ever entering or affecting the brain. Tune in to find out how it works. And, more importantly, will it work?
Overview
Dr. Larry Kaskel is joined by Dr. Frank Vocci, Director of the Division of Pharmacotherapies and Medical Consequences of Drug Abuse at the National Institute on Drug Abuse at the NIH. He will discuss NicVAX, an anti-smoking vaccine that keeps nicotine molecules from ever entering or affecting the brain. Tune in to find out how it works. And, more importantly, will it work?
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Beyond Plaques: Current Concepts in Alzheimer’s Pathophysiology
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
Identifying the Great Imitator – Demystifying the Systemic Features of IgG4-Related Disease
IgG4-RD Case Conversations: The Peculiarities of Kidney Involvement
IgG4-RD Case Conversations: Retroperitoneal Fibrosis with Refractory Ureteral Involvement
Optimizing PPD Diagnosis and Treatment: The Role of Neuroactive Steroids and Multidisciplinary Care
HF Management for Patients with Comorbid Conditions
Collaborative Insights to Solve the Puzzle of Bladder Cancer
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?